Key result
A 30-day rehabilitation program is linked to reduced serum titin levels in sarcopenic patients.
Why the study?
New biomarkers are needed for the diagnosis, monitoring, and treatment of sarcopenia, and the potential of serum titin and its N-terminal fragment has not been widely evaluated.
Do serum TTN, N-TTN, and miR-451a levels serve as biomarkers for sarcopenia and respond to a 30-day rehabilitation program in elderly patients?
Observational (n=160)
Yes
Do serum TTN, N-TTN, and miR-451a levels serve as biomarkers for sarcopenia and respond to a 30-day rehabilitation program in elderly patients?
Serum TTN, N-TTN, and miR-451a are potential biomarkers for sarcopenia that are modulated by a 30-day structured rehabilitation program in elderly patients.
This is the authors' abstract. We don't add key points for this paper.
Introduction: Sarcopenia is a clinical syndrome characterized by decline of muscle mass, strength or physical performance that occur with advancing age. Diagnosis is currently based on assessment of muscle mass and performance. New biomarkers are needed in clinical practice for diagnosis, monitoring and treatment of sarcopenia. The measurement in urine of titin (TTN), a muscular protein essential for structure and function of sarcomere, has been recently suggested as useful biomarker for the diagnosis of sarcopenia. The titin N-terminal fragment (N-TTN), produced by proteolysis during muscle damage, is released in the bloodstream and is secreted in the urine, and it was suggested as indicator of muscle injury. The primary aim of our study is to evaluate the potential of serum TTN and N-TTN expression as biomarker of sarcopenia, an aspect that has not been the subject of much research so far. Additionally, the secondary aim is to explore possible relationship between the serum expression of titin and miR-451a, its possible miRNA regulator. Methods: We verified serum TTN, N-TTN and miR-451a concentration in a cohort of 70 sarcopenic patients who were undergoing rehabilitation; results were compared to those obtained in 90 age- and sex-matched healthy controls (HC). Results: Results showed that TTN and N-terminal TTN (N-TTN) (p < 0.0005 for both) and miR-451a (p < 0.0001) were significantly upregulated in serum of patients compared to HC. Rehabilitation significantly reduced TTN and N-TTN expression (p < 0.05 for all), while induced a significant increase in miR-451a expression (p = 0.008); ROC analysis showed that the change of miR-451a may be a predictive biomarker for rehabilitation outcome (p = 0.0198). Discussion: This study suggests the involvement of TTN, N-TTN and miR-451a in sarcopenia; moreover, the monitoring of miR-451a concentration may be useful proxy to measure the effectiveness of rehabilitation intervention.
Answers are grounded in this paper and cite their sources.
Titin fragments may track sarcopenia and short-term rehab response in elderly; leaves open prospective validation before clinical adoption.
No takes yet. Share an insight, caveat, or question.
Mancuso et al. (2025) conducted an observational in Sarcopenia (n=160). Structured rehabilitation treatment vs. Healthy controls (for baseline comparison) was evaluated on Serum titin (TTN) and N-terminal titin (N-TTN) concentration (p=<0.0005). Serum concentrations of titin and N-terminal titin were significantly upregulated in sarcopenic patients compared to healthy controls and were significantly reduced following a 30-day rehabilitation program.
Synapse has enriched 10 related papers. Consider them for comparative context: